Sign in

CIK 0001604191 · Non-accelerated filer<br>Smaller reporting company

GridAI Technologies Corp.

Sign in to watch
Ticker
GRDX
Exchange
Nasdaq
Industry
Electric & Other Services Combined
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464993860
Phone
561-589-7020
Business address
433 PLAZA REAL, SUITE 275, BOCA RATON, FL
Former names
Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
  1. 4 Open-market sale Chief Financial Officer sold 727 shares at $0.64 ($465)
  2. 4 Open-market sale Chief Financial Officer sold 476 shares at $0.45 ($212)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Chief Financial Officer sold 621 shares at $1.07 ($664)
  5. 4 Open-market sale Chairman and CEO sold 1,289 shares at $1.07 ($1,379)
  6. 4 Grant or award Director acquired 24,889 shares (grant or award)
  7. 4 Open-market sale Chairman and CEO sold 174 shares at $4.23 ($736)
  8. 4 Open-market sale Chief Financial Officer sold 75 shares at $4.23 ($317)
  9. 4 Open-market sale Chairman and CEO sold 1,887 shares at $4.96 ($9,360)
  10. 4 Open-market sale Chief Financial Officer sold 1,120 shares at $4.96 ($5,555)
  11. 4 Grant or award President & COO acquired 15,400 shares (grant or award)
  12. 4 Grant or award Director acquired 440 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Chief Financial Officer sold 98 shares at $4.20 ($412)
  16. 4 Open-market sale Chairman, President and CEO sold 166 shares at $4.20 ($697)
  17. 4 Grant or award Director acquired 19,633 shares (grant or award)
  18. 4 Grant or award Director acquired 19,633 shares (grant or award)
  19. 4 Grant or award Director acquired 19,633 shares (grant or award)
  20. 4 Grant or award Director acquired 19,633 shares (grant or award)

Page 2 of 10 · 181 filings